Study Purpose: This study aims to see how well a medicine called tozorakimab works for patients with a viral lung infection who need extra oxygen. Doctors want to see if it can help prevent death or the need for machines like ventilators.
Eligibility: You can join if you’re 18+ and in the hospital with a viral lung infection needing more oxygen. Hypoxaemia means your blood oxygen level is low (SpO2 ≤ 90% or ≤ 92% with certain breathing issues). You can't join if you have specific lung infections or already need a ventilator.
Key Points to Consider:
- Duration: The study length and number of visits will be explained by your doctor.
- Compensation: You may receive compensation for participating.
- Risks: Discuss any potential risks with your healthcare provider before joining.
This study is important for understanding if tozorakimab can help people with serious lung infections breathe better and stay healthy.
How understandable was the trial content above?
Hard to understand
Easy to understand